Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NutriCaps is a biotechnology and specialized CDMO company that focuses on the development of advanced microencapsulation solutions for the pharmaceutical, nutraceutical, and functional food industries. The company utilizes proprietary technology to protect sensitive bioactive compounds—such as probiotics, enzymes, and vitamins—from environmental degradation and gastrointestinal transit, ensuring targeted release and enhanced bioavailability. With operations in Switzerland and Portugal, NutriCaps provides end-to-end services ranging from formulation development to large-scale encapsulation and packaging. Their platform is particularly noted for its ability to stabilize liquid-filled hard capsules and multi-particulate delivery systems, making it a key partner for companies looking to optimize the delivery of complex or sensitive active ingredients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NutriCaps.